Desarrollo de Vacunas
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (3)
2022
-
Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy
Journal of Hepatology
2020
-
Cold‐inducible rna binding protein as a vaccination platform to enhance immunotherapeutic responses against hepatocellular carcinoma
Cancers, Vol. 12, Núm. 11, pp. 1-18
2019
-
Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
Frontiers in Immunology, Vol. 10